OPA1 and Huntington disease: Some of the phenotypes present in HD iPSCs persisted in HD iPSC-derived NPCs, including increased lysosomal activity [24], reduced proteasome activity [32], increased resistance to manganese cytotoxicity [40], metabolic alterations [61], and mitochondria number, density, and OPA1 co-localisation impairments [61].